Pasi A. Jänne
0000-0002-7821-4928
Publication & Citation Trends
Publications
0 total
YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Cited by 0
Semantic Scholar
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
Cited by 0
Semantic Scholar
Trastuzumab deruxtecan in HER2-mutant metastatic non-small-cell lung cancer: a plain language summary of the DESTINY-Lung02 study
Cited by 0
Semantic Scholar
mSWI/SNF complex inhibition sensitizes KRAS-mutant lung cancers to targeted therapies via epithelial-mesenchymal subversion
Cited by 0
Semantic Scholar
Abstract 6473: Clonal consolidation and transcriptional re-programming define non-small cell lung cancers resistant to immune checkpoint inhibitors
Cited by 0
Semantic Scholar
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Cited by 1
Semantic Scholar
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment OA
Cited by 18
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(1550)
Cancer Genomics and Diagnostics
(395)
Colorectal Cancer Treatments and Studies
(380)
Lung Cancer Research Studies
(352)
HER2/EGFR in Cancer Research
(314)
Affiliations
AstraZeneca (United Kingdom)
Broad Institute
Boston University
University of North Carolina at Chapel Hill
Ulsan College